This study is testing ways to help patients with metastatic breast cancer remember to take their medicines as prescribed. Metastatic means the cancer has spread to other parts of the body. The study focuses on patients using a type of medicine called CDK4/6 inhibitors, which must be taken following a specific schedule. CDK4/6 inhibitors are a group of drugs used to treat this type of cancer. Some patients will use a WiseBag, a special medication dispenser, while others will also receive text reminders through a program called CONCURxP.

Key Points:

• Participants will be in the study for 12 months and must be able to send and receive texts.
• Patients will either use a WiseBag alone or with the extra help of the CONCURxP platform.
• Compensation may include gift cards for survey completion, but no other financial assistance.